Navigation Links
Advanced Instruments Acquires Mart Microbiology B.V.
Date:11/19/2007

NORWOOD, Mass., Nov. 19 /PRNewswire/ -- Advanced Instruments, Inc., of Norwood, Massachusetts, announced today that it has acquired 100% of the shares of Mart Microbiology B.V. of The Netherlands. The terms of the transaction were not disclosed.

Mart Microbiology manufactures and markets the Anoxomat(TM) line of instruments. These systems create custom environments for anaerobic bacteria cultivation, a process which requires oxygen-deprived atmospheres. Typical applications include the diagnosis of post-operative infection in hospitals and clinics, plus bacterial cultivation in food microbiology labs.

Anoxomat provides many advantages over traditional methods of cultivating anaerobes. The system can quickly create a precision anaerobic environment that enables reliable and rapid bacteria cultivation. It uses less lab space than traditional "glove box" cabinets and can provide typical returns on investment in less than one year.

Advanced Instruments has been the U.S. distributor of Anoxomat products for more than 6 years and has placed many systems at leading American medical centers. In addition, Mart products are sold in other global regions through an established factory-trained dealer network.

"Mart Microbiology is a perfect fit for our company," said John Coughlin, President and CEO, Advanced Instruments. "It is the clear market leader in this developing technology and compliments our company's market presence globally. The experience gained as Anoxomat's U.S. distributor gives us a high degree of confidence in making this strategic move," he said.

Advanced Instruments currently operates a facility in The Netherlands and the operations of Mart Microbiology will be integrated into that facility in early 2008.

About Advanced Instruments, Inc.

Founded in 1955, Advanced Instruments, Inc. is the world's largest supplier of freezing-point osmometers used in clinical, pharmaceutical, and biotechnology laboratories. The company is also a leading supplier of analytical instruments and test kits for the food, dairy, and industrial microbiology markets. Based in Norwood, Massachusetts, USA, the privately held company also produces Fiske(R) Associates brand diagnostic instruments and operates Spiral Biotech, Inc., and Delta Instruments as wholly-owned subsidiaries.

Advanced Instruments' products are supported by a worldwide network of direct sales people and independent distributors. Reach Advanced Instruments online at http://www.aicompanies.com or contact us at 800-225-4034 or +1-781-320-9000.


'/>"/>
SOURCE Advanced Instruments, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):